Axons degenerate in a range of neurological disorders, such as mechanical injury, chemotherapy-induced neuropathy, hereditary neuropathies, glaucoma, diabetes and the neurodegenerative diseases Alzheimer's disease and Parkinson's disease 1 . Degenerating axons follow a stereotyped pathological progression that was first described in the 1850s for the breakdown of the distal segments of severed axons and was termed Wallerian degeneration 2 . This degeneration probably results from an active self-destruction program rather than from passive deterioration 2 , as it is delayed by overexpression of the chimeric Wallerian degeneration slow 3 (Wld s ) protein and its component nicotinamide mononucleotide adenylyltransferase 4, 5 , by preventing Ca 2+ influx 6 , by blocking protein degradation 7 , and by disrupting the phagocytic clearance of axon fragments 8 . A variety of insults trigger axon degeneration 2, 9 and identifying the components of the hypothesized axon self-destruction program could have broad clinical value. To date, however, no loss-of-function mutations have been identified that disrupt the internal axon breakdown machinery and the internal signaling pathways that orchestrate axon breakdown in injury and disease remain unknown.
Candidate components of axon breakdown pathways should be present in axons and should be activated by diverse cellular insults. One such candidate is dual leucine kinase (DLK), a mitogen-activated protein kinase kinase kinase (MAP3K) 10 . One of DLK's downstream targets, the mitogen-activated protein kinase (MAPK) c-Jun Nterminal kinase (JNK), is activated following axonal injury 11 . We tested the hypothesis that DLK promotes axon degeneration using a wellestablished Drosophila olfactory receptor neuron (ORN) axotomy model 8, 12 ( Fig. 1 , complete methods are provided in the Supplementary Methods online). We expressed green fluorescent protein (GFP) in ORNs to visualize their axons, which extend from cell bodies in the antennae into the antennal lobes of the brain and across a midline commissure (Fig. 1a) . To sever ORN axons and induce degeneration, we removed the antennae from wild-type flies and mutants lacking the Drosophila ortholog of DLK, wallenda (wnd) 13 . Most wild-type axons degenerated in 24 h (Fig. 1b) , whereas wnd mutant axons were significantly preserved (P o 0.001; Fig. 1c ). Wnd is therefore required for normal axon degeneration in Drosophila.
Wnd could act in neurons to promote breakdown after injury or in surrounding cells to promote axon clearance. To distinguish between these possibilities, we expressed Wnd in the GFP-expressing subpopulation of ORNs in wnd mutant flies. Such Wnd expression was not © 2009 Nature America, Inc. All rights reserved. sufficient to induce degeneration in the absence of injury. However, we found that the Wnd-expressing axons of these otherwise wnd mutant flies were not preserved 24 h after axotomy (Fig. 1d) . Thus, Wnd functions in an internal neuronal pathway that promotes injury-induced axon degeneration. Wnd may selectively promote injury-induced axon degeneration, as we found no defects in the developmental pruning of mushroom body gamma-lobe axons (data not shown).
To determine whether DLK promotes Wallerian degeneration in mammals, we used dorsal root ganglion (DRG) cultures from littermate wild-type (Fig. 2a-c) and DLK-deficient (Fig. 2d-f ) embryos 14 ( Supplementary Fig. 1 online) . We severed DRG axons to induce degeneration and evaluated the degeneration of the distal axon segment. Wild-type axons distal to the transection deteriorated into axon fragments 24 h after severing, whereas DLK-deficient axons retained their continuity (Fig. 2b,e) . To quantify the extent of axon fragmentation, we measured the fraction of total axonal area that was occupied by axon fragments (degeneration index) and found that DLK-deficient axons were significantly preserved (P o 0.001; Fig. 2b,e) . This delay in fragmentation persisted for 48 h ( Supplementary Fig. 2 online) . Because non-neuronal cells are eliminated in this DRG culture system, DLK must operate in mammalian neurons to promote axon breakdown. Neuronal DLK therefore promotes axon fragmentation after injury in flies and mice.
To determine whether DLK promotes degeneration in response to multiple insults, we assessed the response of DLK-deficient DRG axons to vincristine, a chemotherapeutic drug that induces axon degeneration in vitro and whose dose-limiting side effects in patients include neuropathy 15 . We found that DLK-deficient axons were significantly protected from vincristine-induced fragmentation (P o 0.002; Fig. 2c,f) , suggesting that DLK operates in a general axon breakdown program.
To determine whether disrupting DLK protects injured axons in vivo, we transected the sciatic nerves of littermate wild-type and DLKdeficient adult mice (Fig. 2g-l) . Wild-type axons degenerated 52 h post-transection, whereas DLK-deficient axons were significantly preserved (P o 0.007; Fig. 2h,i) . Electron microscopy revealed that preserved axon profiles contained mitochondria and a cytoskeleton ( Fig. 2l and Supplementary Fig. 3 online) 
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In vivo sciatic nerve transections in adult mice. Sciatic nerve cross-sections distal to the transection site were stained with Toluidine blue (g-i) or imaged by electron microscopy (j-l).
Axons were significantly preserved in DLK-deficient nerves 52 h post-axotomy (208 ± 22% axon profiles per mm 2 compared with wild-type nerves, P o 0.007, Student's t test, n ¼ 4 wild-type animals and 5 DLK mutant animals; h,i). Electron microscopy showed that these profiles contained axons with mitochondria and a cytoskeletal network (j-l; see Supplementary  Fig. 3 ). Scale bars represent 20 mm (a-i) and 2 mm (j-l). All mouse experiments were approved by the Washington University School of Medicine Animal Studies Committee. DLK is a MAP3K that can activate JNK and p38 via intermediary MAP2Ks 10 . To determine whether either downstream kinase promotes axon degeneration, we inhibited JNK and p38 in the DRG axotomy model using wild-type cultures. Inhibition of JNK, but not p38, significantly protected transected axons from fragmentation (P o 0.001; Fig. 3a-e) and a significant delay in fragmentation persisted for over 48 h (P o 0.001; Supplementary Fig. 2 ). Thus JNK, similar to DLK, acts in neurons to promote axon degeneration.
Axon degeneration is hypothesized to comprise at least three distinct phases: competence to degenerate, much of which is determined transcriptionally before axotomy, commitment to degenerate, which occurs in the substantial delay period between injury and axon fragmentation, and the execution phase, when axons fragment 1 . If JNK's primary role were to promote competence to degenerate, then JNK activity should be required before axotomy. This is not the case, as applying the JNK inhibitor 24 h before axotomy and then removing it just before axotomy was not protective (Fig. 3f) . In contrast, JNK inhibition started concurrently with axotomy was significantly protective (P o 0.001; Fig. 3g ). Thus, JNK promotes axon fragmentation after the competence period and acts in the severed distal axon segment.
JNK could commit axons to degenerate during the delay between injury and breakdown or it could operate during the subsequent execution phase of axon breakdown. To test whether JNK activity is required during the execution phase, we added the JNK inhibitor 3 h after axotomy, which is approximately 9 h before the onset of fragmentation. This treatment schedule spans the transition from the proposed commitment phase to the execution phase and the entire execution phase itself. Continuous JNK inhibition beginning 3 h postaxotomy did not delay axon fragmentation (Fig. 3h) . Therefore, JNK activity is not required during the execution phase of axon fragmentation. Instead, JNK activity is required during the early response to injury that commits the axon to breakdown hours later.
Converging lines of evidence suggest that there is a general internal axon self-destruction program, but its molecular components are unknown. We found that the MAP3K DLK and its downstream MAPK JNK are important elements of such a program. Disrupting this pathway delayed axon fragmentation in response to both axotomy and the neurotoxic chemotherapeutic agent vincristine. Thus, a common self-destruction program may promote axon breakdown in response to diverse insults and may be targetable in multiple clinical settings.
Note: Supplementary information is available on the Nature Neuroscience website.
